US Stocks
/
C4 Therapeutics, Inc. Share Price
C4 Therapeutics, Inc. Share Price

C4 Therapeutics, Inc. Share Price

NASDAQ: CCCC | Micro Cap
$3.17
+$0.30 (10.45%) Last updated on 10 Oct, 2026 | 01:29 IST
  • Performance
  • Chart
  • Fundamentals
  • Quarterly P&L
  • Annual P&L
  • About
  • Price history
  • FAQs

C4 Therapeutics, Inc. Stock Performance

Open
$3.01
Prev. Close
$2.87
Circuit Range
N/A
Day Range
$2.96 - $3.19
Year Range
$1.70 - $5.17
Volume
2,06,607
Average Traded
$3.11

C4 Therapeutics, Inc. Share Price Today

As of 10 October 2026, C4 Therapeutics, Inc.'s share price is $3.17. The stock opened at $3.01, compared to its previous close of $2.87. During today's trading session, C4 Therapeutics, Inc.'s share price traded between $2.96 and $3.19, with an average price of $3.07. Over the past 52 weeks, the stock has recorded a high of $5.17 and a low of $1.70. In terms of performance, C4 Therapeutics, Inc.'s share price has risen by 12.01% over the last six months and is up 21.69% on a year-on-year basis.

C4 Therapeutics, Inc. Share Price Chart

$2.96$3.19
L
Show Current Price
H

C4 Therapeutics, Inc. Stock Fundamentals & Key Indicators

Market Cap
$262.78M
PE Ratio (TTM)
N/A
Dividend Yield
0.00%
EPS (TTM)
$-0.82
Revenue (TTM)
$35.95B
Return On Equity (TTM)
-41.02%
Profit Margin
-292.04%
Debt to Equity
0.00
Quarterly Earnings Growth YoY
26.52%

C4 Therapeutics, Inc. Quarterly Profit & Loss

All figures in USD

ParticularsSep 2025Dec 2025Mar 2026Jun 2026
Revenue$11.23$11.02$6.15$6.64
Net Profit-$32.17-$20.49-$25.13-$23.64
Net Profit Margin-286.46%-185.93%-408.62%-356.02%
Income ChangeN/A36.31%-22.65%5.93%

C4 Therapeutics, Inc. Annual Profit & Loss

All figures in USD

Particulars2022202320242025
Revenue$31.10$20.76$35.58$35.95
Net Profit-$128.18-$132.49-$105.32-$104.99
Net Profit Margin-412.15%-638.20%-296.01%-292.04%
Income ChangeN/A-3.36%20.51%0.31%

About C4 Therapeutics, Inc.

C4 Therapeutics Inc is a clinical-stage biopharmaceutical company dedicated to delivering on the promise of targeted protein degradation science to create a new generation of medicines that transforms patient's lives. The Company is progressing targeted oncology programs through clinical studies and leveraging its TORPEDO platform to efficiently design and optimize small-molecule medicines to address difficult-to-treat diseases. The degrader medicines of the company are designed to harness the body's natural protein recycling system to rapidly degrade disease-causing proteins, offering the potential to overcome drug resistance, and drug undruggable targets and improve patient outcomes. Its pipeline is Cemsidomide, CFT8919, and other discovery products.

C4 Therapeutics, Inc. Historical Returns

MonthOpenCloseChange %
Oct 2026
$3.35
$3.17
-4.80%
Sep 2026
$3.69
$3.33
-18.58%
Aug 2026
$3.46
$4.09
+17.19%
Jul 2026
$4.71
$3.49
-24.95%
Jun 2026
$4.34
$4.65
+5.92%
May 2026
$2.77
$4.39
+55.12%
Apr 2026
$2.67
$2.83
+7.60%
Mar 2026
$2.63
$2.63
-2.77%
Feb 2026
$1.89
$2.71
+43.12%
Jan 2026
$1.97
$1.89
-1.05%
Dec 2025
$2.60
$1.91
-29.26%
Nov 2025
$2.60
$2.70
+3.65%

CCCC Share Price FAQs

What is C4 Therapeutics, Inc. share price today?

chevron-up
C4 Therapeutics, Inc. share price today is $3.17 as on October 10, 2026 at 1:29 am IST.

What is the 52 week high and 52 week low of C4 Therapeutics, Inc. stock?

chevron-up
The 52 week high of C4 Therapeutics, Inc. stock is $5.17, while the 52 week low is $1.70 as of 10 Oct '26.

What is CCCC's market capitalisation today?

chevron-up
CCCC market capitalisation is $262.78M as of October 10, 2026, at 5:17 am IST.

What is CCCC's net income for the last quarter?

chevron-up
CCCC's net income for the last quarter is -23.64B USD.

What is the 5 year returns of CCCC?

chevron-up
The 5 year returns of CCCC is -92.87% as on 10 Oct '26.

What is the high & low stock price of CCCC today?

chevron-up
CCCC stock price hit a high of $3.19 and low of $2.96 as of 10 Oct '26.

Can I buy CCCC shares in India?

chevron-up
Yes. You can buy CCCC in India by opening an international trading account.